Franklin Resources Inc Amylyx Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.71 - $19.57 $1.44 Million - $10.4 Million	530,885 Added 40.07%	1,855,886 $5.27 Million
Q4 2023 Feb 09, 2024	BUY	$12.07 - $18.46 $8.54 Million - $13.1 Million	707,134 Added 114.45%	1,325,001 $19.5 Million
Q3 2023 Nov 13, 2023	BUY	$18.08 - $23.45 $10.7 Million - $13.8 Million	589,381 Added 2069.02%	617,867 $11.3 Million
Q2 2023 Aug 11, 2023	BUY	$20.98 - $31.42 $597,636 - $895,030	28,486 New	28,486 $614,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $227M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.